Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001387131-22-012291

Co-CEO & President acquired 373,857 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Zanganeh Mahkam Co-CEO & President 2022-12-06 Other acquisition +373,857 10,930,849 D: show line 1 in the form
Loading xslF345X03/zangeneh-form4_120622.xml…